Veeva DQS Cleans Data for Over 1 Million Participants in More Than 1,000 Studies
Veeva Systems announced its Veeva DQS system has cleaned data for over one million participants across more than 1,000 clinical studies. The system automates data reconciliation, offering significant cost and time savings.
Veeva Systems announced that its Veeva DQS system has processed data for over one million participants from more than 1,000 clinical studies. The data cleaning system automates data reconciliation, leading to substantial savings in cost, time, and effort for clinical teams.
In a release from Barcelona, Spain, dated October 6, 2026, Veeva Systems (NYSE: VEEV) highlighted that Veeva DQS is now widely adopted by various pharmaceutical and biotechnology companies. The goal is to enhance the efficiency and data quality of clinical trials.
With automated reconciliation, clinical teams can redirect resources toward analysis and decision-making, rather than dedicating time to manual data review. This is particularly beneficial for large-scale, complex global studies with extensive data volumes.
The implementation of Veeva DQS facilitates faster and more accurate data management, which is expected to accelerate the drug development process and improve the reliability of study outcomes. The company continues to evolve its platform to meet growing industry demands.